Science Daily (Sandy Hook, CT: 15.1 million unique monthly visits)
Publicized in: ACS PressPac
February 5, 2018
Artificial sweeteners are used in diet drinks and foods but also could someday be used as treatments targeting carbonic anhydrase IX (CA IX), a protein associated with aggressive cancers. Although several drugs have been approved that target similar forms of CA, they aren’t selective and may cause side effects, including vomiting and fatigue. Now researchers report in ACS’ Journal of Medicinal Chemistry that an artificial sweetener could lead to development of a more selective therapy.
Nine media outlets, including Phys.Org (Tilburg, Netherlands: 9.3 million unique monthly visits), News Medical (Sydney, Australia: 6.5 million unique monthly visits), Laboratory Equipment (Rockaway, NJ: 685,600 unique monthly visits), Canada Free Press (Canada: 415,300 unique monthly visits), Technology Networks (Canada: 88,000 unique monthly visits) and Bioscience Technology (Rockaway, NJ: 73,000 unique monthly visits), covered the story.